UNIVERSAL PHARMACY LTDActive

Company number 07534072Private limited companyIncorporated 2011
⚠ Accounts overdue. The next accounts were due on 31 Mar 2025 and had not been filed when the register was last updated.
⚠ Confirmation statement overdue. It was due on 30 Jan 2026.

Key figures

£6,649-97.6%
Net assets 2021/22
-84.1%
Average annual change 2019/20–2021/22
0100 k200 k300 k2019/202020/212021/22

Like most small UK companies, UNIVERSAL PHARMACY LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2021/22
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m3 m2019/202020/212021/22
Filed accounts2019/20–2021/22
2019/202020/212021/22
Cash at bank and in hand3,8826,011151,437
Total assets1,925,8871,989,1742,416,038
Total liabilities———
Net assets / total equity263,063272,2276,649
Average number of employees222630

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: UNIVERSAL PHARMACY LTD

Company

UNIVERSAL PHARMACY LTD is a private limited company registered with Companies House under company number 07534072. It was incorporated on 17 Feb 2011. Its status is active. The registered office is in Brighton (BN1). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2021/22 (period ending 31 Mar 2022); the company files small company accounts (filleted). Net assets were £6,649, down 97.6% on the previous year. Cash at bank and in hand was £151,437. The company had an average of 30 employees. Figures are available for 3 financial years (2019/20–2021/22).

Control and charges

One person with significant control is registered. 2 of 10 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Mar 2025. The next confirmation statement is due by 30 Jan 2026.